Beijing SL Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Net Income	83.77	-74.07	416.69	234.4	425.94	364.71
Depreciation & Amortization	152.94	152.94	145.4	113.88	99.8	89.49
Other Amortization	0.29	0.29	0.28	0.17	0.17	0.17
Loss (Gain) From Sale of Assets	-	-	-	-0.21	-3.22	0
Asset Writedown & Restructuring Costs	-0	-0	-0.01	0	0.02	0.02
Loss (Gain) From Sale of Investments	159.17	159.17	-239.47	-98.13	-209.01	-239.36
Provision & Write-off of Bad Debts	9.49	9.49	23.81	31.94	26.25	5.84
Other Operating Activities	-290.55	0.94	1.05	-5.99	-4.38	-2.86
Change in Accounts Receivable	62.45	62.45	19.66	82.88	108.64	198.78
Change in Inventory	-102.33	-102.33	-4.25	0.58	-11.5	-3.69
Change in Accounts Payable	68.51	68.51	66.58	36.56	17.54	-22.72
Change in Other Net Operating Assets	-	-	-	-	-	-0.12
Operating Cash Flow	91.82	225.49	460.2	389.82	464.63	415.84
Operating Cash Flow Growth	-74.76%	-51.00%	18.05%	-16.10%	11.73%	-37.55%
Capital Expenditures	-377.53	-347.38	-218.36	-163.49	-236.91	-255.95
Sale of Property, Plant & Equipment	0	0	0.01	1.47	7.49	0.01
Divestitures	-	-	-	-4.88	-	-
Investment in Securities	81.58	-33.46	-86.95	-384.76	-0.96	-560.67
Other Investing Activities	164.14	169.29	-39.35	11.25	32.55	-25.53
Investing Cash Flow	-131.8	-211.55	-344.65	-540.4	-197.82	-842.14
Short-Term Debt Issued	-	-	-	-	5.5	7.17
Total Debt Issued	-	-	-	-	5.5	7.17
Short-Term Debt Repaid	-	-	-	-	-14.5	-8.27
Long-Term Debt Repaid	-	-	-	-	-0.4	-
Total Debt Repaid	-	-	-	-	-14.9	-8.27
Net Debt Issued (Repaid)	-	-	-	-	-9.4	-1.1
Common Dividends Paid	-20.55	-154.1	-102.74	-102.74	-102.93	-205.82
Other Financing Activities	-	-	-	-	9	-
Financing Cash Flow	-20.55	-154.1	-102.74	-102.74	-103.33	-206.92
Foreign Exchange Rate Adjustments	0	-0	0.03	0.1	-0.02	0.08
Net Cash Flow	-60.52	-140.17	12.84	-253.21	163.45	-633.15
Free Cash Flow	-285.7	-121.89	241.84	226.33	227.72	159.89
Free Cash Flow Growth	-	-	6.85%	-0.61%	42.42%	-59.32%
Free Cash Flow Margin	-49.38%	-18.46%	23.75%	21.55%	18.75%	14.37%
Free Cash Flow Per Share	-0.27	-0.12	0.24	0.22	0.22	0.16
Cash Income Tax Paid	21.25	39.14	88.16	91.55	85.63	112.23
Levered Free Cash Flow	-581.12	-260.4	186.77	121.34	113.97	94.8
Unlevered Free Cash Flow	-581.12	-260.4	186.77	121.4	114.11	95.02
Change in Working Capital	-23.28	-23.28	112.45	113.75	129.06	197.82

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.